- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Raptor Pharmaceuticals Corp. (RPTP) and TorreyPines Therapeutics, Inc. (TPTX) Completes Merger
Recent Articles by BenzingaStaff1
- ATP Oil & Gas Corporation (ATPG) Declares Cash Dividend on Preferred Stock
- Crane Co. (CR) to Acquire Merrimac Industries
- Brady Corporation (BRC) Acquires Custom-Label and Nameplate Manufacturer in Brazil
- Carrollton Bancorp (CRRB) Announces Appointment of Mark A. Semanie as Chief Financial Officer
- Energy Transfer (ETE) Announces Appointment of New Directors
Company News
- Nike (NKE) Upgraded
- Large Trade in Hartford
- LSI Corporation (LSI) Upgraded To Buy; Price Target Raised
- Burger King (BKC) Upgraded
- Credit Suisse Maintains Public Service Enterprise Group (PEG) Outperform Rating
Press Releases
Posted on 09/30/09 at 7:04am by Ben Zinga
Raptor Pharmaceuticals Corp. (OTC: RPTP) and TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced the completion of merger. The new entity will be called Raptor Pharmaceutical Corp. and to trade under NASDAQ Ticker "RPTP". It will be headquartered in Novato, California and managed by Raptor's existing management team.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- Raptor Pharmaceuticals Corp. and TorreyPines Complete MergerCreates Biopharmaceutical Company Named Raptor Pharmaceutical Corp. to Trade Under NASDAQ Ticker "RPTP"
- Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to MergeMerger to Create NASDAQ-Listed Biopharmaceutical Company named Raptor Pharmaceutical Corp.
- Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders
- Raptor Pharmaceuticals Raises $5 Million
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
